
Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
Mike Johnston, CPhT-Adv, CEO of NPTA, detailed how independent pharmacies can transform their staffing from a chronic shortage into a high-performing engine.
With turnover rates averaging 60%, many pharmacy owners find themselves trapped in a reactive hiring cycle that often leads to desperate, poor-fit hires.






